Connection

NATHAN FOWLER to Bridged Bicyclo Compounds, Heterocyclic

This is a "connection" page, showing publications NATHAN FOWLER has written about Bridged Bicyclo Compounds, Heterocyclic.
  1. BCL-2 inhibition in follicular lymphoma: can we tip the scales? Blood. 2020 12 03; 136(23):2598-2600.
    View in: PubMed
    Score: 0.115
  2. Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients. Am J Hematol. 2020 06; 95(6):623-629.
    View in: PubMed
    Score: 0.110
  3. Ibrutinib and Venetoclax for First-Line Treatment of CLL. N Engl J Med. 2019 05 30; 380(22):2095-2103.
    View in: PubMed
    Score: 0.104
  4. Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia: A Nonrandomized Phase 2 Trial. JAMA Oncol. 2021 Aug 01; 7(8):1213-1219.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.